Topical Application of a Mast Cell Stabilizer Improves Impaired Diabetic Wound Healing
Ana Tellechea(Beth Israel Deaconess Medical Center), Aristidis Veves(Beth Israel Deaconess Medical Center), Swati S. Bhasin(Emory University), Manoj Bhasin(Emory University), Georgios Theocharidis(Beth Israel Deaconess Medical Center), Sha Bai(Beth Israel Deaconess Medical Center), Lijun Sun(North West Agriculture and Forestry University), Yongjun Zheng(Naval Medical Research Command), Seema Dangwal(Beth Israel Deaconess Medical Center), Konstantinos Kounas(Beth Israel Deaconess Medical Center), Smaro Panagiotidou(Tufts University), Ting‐Yu Shih(Boston University), Steffi Koerner(Beth Israel Deaconess Medical Center), Theoharis C. Theoharides(Nova Southeastern University), Wanni Zhao(Capital Medical University), Xiaoli Li(Fujian Medical University), Cuiping Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), David Mooney(Harvard University), Masa Nagai(Beth Israel Deaconess Medical Center), Jae Eun Cheong(Beth Israel Deaconess Medical Center)
Cited by 85
Related Papers
Graftskin, a Human Skin Equivalent, Is Effective in the Management of Noninfected Neuropathic Diabetic Foot Ulcers
|Diabetes Care|2001|765
Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.
|Diabetes Care|2000|651
Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.
|Diabetes|1999|649
Tissue Engineering by Cell Transplantation Using Degradable Polymer Substrates
|Journal of Biomechanical Engineering|1991|595
The tensile properties of alginate hydrogels
|Biomaterials|2003|562